Roswell Park Study Shows Venetoclax Enhances CAR T Immune Response for CLL
January 3, 2025
A new treatment approach developed at Roswell Park Comprehensive Cancer Center has shown promising results in a phase 1 clinical trial for patients with triple-negative breast